Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Svitlana Garbuzova-Davis, Avery Thomson, Crupa Kurien, R. Douglas Shytle & Paul R. Sanberg. (2016) Potential new complication in drug therapy development for amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 16:12, pages 1397-1405.
Read now
Read now
Melissa Nassif, Vicente Valenzuela, Diego Rojas-Rivera, René Vidal, Soledad Matus, Karen Castillo, Yerko Fuentealba, Guido Kroemer, Beth Levine & Claudio Hetz. (2014) Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy 10:7, pages 1256-1271.
Read now
Read now
Stefanie Saenger, Bettina Holtmann, Mark R. Nilges, Susanne Schroeder, Andreas Hoeflich, Heidemarie Kletzl, Will Spooren, Susanne Ostrowitzki, Taleen Hanania, Michael Sendtner & Friedrich Metzger. (2012) Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity. Amyotrophic Lateral Sclerosis 13:5, pages 418-429.
Read now
Read now
Jia Li, Jill M. Paulson, Felix D. Ye, Minhee Sung, Anthony N. Hollenberg & Seward B. Rutkove. (2012) Reducing systemic hypermetabolism by inducing hypothyroidism does not prolong survival in the SOD1-G93A mouse. Amyotrophic Lateral Sclerosis 13:4, pages 372-377.
Read now
Read now
Albert C. Ludolph, Caterina Bendotti, Eran Blaugrund, Adriano Chio, Linda Greensmith, Jean-Philippe Loeffler, Richard Mead, Heiko G. Niessen, Susanne Petri, Pierre-Francois Pradat, Wim Robberecht, Markus Ruegg, Birgit Schwalenstöcker, Detlev Stiller, Leonard van den Berg, Fernando Vieira & Stephan von Horsten. (2010) Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotrophic Lateral Sclerosis 11:1-2, pages 38-45.
Read now
Read now
Vincent Meininger, Vivian E. Drory, P. Nigel Leigh, Albert Ludolph, Wim Robberecht & Vincenzo Silani. (2009) Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial. Amyotrophic Lateral Sclerosis 10:5-6, pages 378-383.
Read now
Read now
Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi & Gen Sobue. (2008) A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. Expert Opinion on Pharmacotherapy 9:11, pages 1845-1857.
Read now
Read now
. (2008) SESSION 6A USE OF THE G93A SOD1 MOUSE IN THERAPEUTIC TESTING. Amyotrophic Lateral Sclerosis 9:sup1, pages 19-20.
Read now
Read now
Articles from other publishers (73)
Ronald Sluyter, Sahil Adriouch, Stephen J. Fuller, Annette Nicke, Reece A. Sophocleous & Debbie Watson. (2023) Animal Models for the Investigation of P2X7 Receptors. International Journal of Molecular Sciences 24:9, pages 8225.
Crossref
Crossref
Yingzhen Zhang, Lin Chen, Zhongzhong Li, Dongxiao Li, Yue Wu & Yansu Guo. (2022) Endothelin-1, over-expressed in SOD1G93A mice, aggravates injury of NSC34-hSOD1G93A cells through complicated molecular mechanism revealed by quantitative proteomics analysis. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Tiziana Bonifacino, Roberta Arianna Zerbo, Matilde Balbi, Carola Torazza, Giulia Frumento, Ernesto Fedele, Giambattista Bonanno & Marco Milanese. (2021) Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives. International Journal of Molecular Sciences 22:22, pages 12236.
Crossref
Crossref
Marco Milanese, Tiziana Bonifacino, Carola Torazza, Francesca Provenzano, Mandeep Kumar, Silvia Ravera, Arianna Roberta Zerbo, Giulia Frumento, Matilde Balbi, T. P. Nhung Nguyen, Nadia Bertola, Sara Ferrando, Maurizio Viale, Aldo Profumo & Giambattista Bonanno. (2021)
Blocking glutamate mGlu
5
receptors with the negative allosteric modulator CTEP improves disease course in SOD1
G93A
mouse model of amyotrophic lateral sclerosis
. British Journal of Pharmacology 178:18, pages 3747-3764.
Crossref
Crossref
Jessica R. Morrice, Michael Kuo & Christopher A. Shaw. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
181
199
.
Lin Bai, Yafei Wang, Jia Huo, Shuai Li, Ya Wen, Qi Liu, Jing Yang, Yaling Liu & Rui Li. (2021) Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles. Cell Death & Disease 12:4.
Crossref
Crossref
Mathieu Charvériat, Vincent Lafon, Franck Mouthon & Luc Zimmer. (2021) Innovative approaches in CNS drug discovery. Therapies 76:2, pages 101-109.
Crossref
Crossref
Chunting Zhang, Hongyong Wang, Weiwei Liang, Yueqing Yang, Chaohua Cong, Ying Wang, Shuyu Wang, Xudong Wang, Di Wang, Di Huo & Honglin Feng. (2021) Diphenyl diselenide protects motor neurons through inhibition of microglia-mediated inflammatory injury in amyotrophic lateral sclerosis. Pharmacological Research 165, pages 105457.
Crossref
Crossref
Aude Chiot, Sakina Zaïdi, Charlène Iltis, Matthieu Ribon, Félix Berriat, Lorenzo Schiaffino, Ariane Jolly, Pierre de la Grange, Michel Mallat, Delphine Bohl, Stéphanie Millecamps, Danielle Seilhean, Christian S. Lobsiger & Séverine Boillée. (2020) Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nature Neuroscience 23:11, pages 1339-1351.
Crossref
Crossref
Liping Liu, Kelby M. Killoy, Marcelo R. Vargas, Yasuhiko Yamamoto & Mariana Pehar. (2020)
Effects of RAGE inhibition on the progression of the disease in hSOD1
G93A
ALS mice
. Pharmacology Research & Perspectives 8:4.
Crossref
Crossref
Jan Vollert, Esther Schenker, Malcolm Macleod, Anton Bespalov, Hanno Wuerbel, Martin Michel, Ulrich Dirnagl, Heidrun Potschka, Ann-Marie Waldron, Kimberley Wever, Thomas Steckler, Tom van de Casteele, Bruce Altevogt, Annesha Sil & Andrew S C Rice. (2020) Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals. BMJ Open Science 4:1, pages e100046.
Crossref
Crossref
Honglin Tan, Mina Chen, Dejiang Pang, Xiaoqiang Xia, Chongyangzi Du, Wanchun Yang, Yiyuan Cui, Chao Huang, Wanxiang Jiang, Dandan Bi, Chunyu Li, Huifang Shang, Paul F. Worley & Bo Xiao. (2019) LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice. Cell Death & Differentiation 27:4, pages 1369-1382.
Crossref
Crossref
Yue-Qing Yang, Yong-Hui Zheng, Chun-Ting Zhang, Wei-Wei Liang, Shu-Yu Wang, Xu-Dong Wang, Ying Wang, Tian-Hang Wang, Hong-Quan Jiang & Hong-Lin Feng. (2020) Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis. Neurobiology of Disease 134, pages 104648.
Crossref
Crossref
John D. Lee, Ning Liu, Samantha C. Levin, Lars Ottosson, Ulf Andersson, Helena E. Harris & Trent M. Woodruff. (2019) Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Neuroinflammation 16:1.
Crossref
Crossref
Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley & I Anna S Olsson. (2019) Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review. BMJ Open Science 3:1, pages e000016.
Crossref
Crossref
J. A. Clark, C. A. Blizzard, M. C. Breslin, E. J. Yeaman, K. M. Lee, J. A. Chuckowree & T. C. Dickson. (2018)
Epothilone D accelerates disease progression in the SOD1
G93A
mouse model of amyotrophic lateral sclerosis
. Neuropathology and Applied Neurobiology 44:6, pages 590-605.
Crossref
Crossref
Najwa Ouali Alami, Christine Schurr, Florian Olde Heuvel, Linyun Tang, Qian Li, Alpaslan Tasdogan, Atsushi Kimbara, Matthias Nettekoven, Giorgio Ottaviani, Catarina Raposo, Stephan Röver, Mark Rogers‐Evans, Benno Rothenhäusler, Christoph Ullmer, Jürgen Fingerle, Uwe Grether, Irene Knuesel, Tobias M Boeckers, Albert Ludolph, Thomas Wirth, Francesco Roselli & Bernd Baumann. (2018) NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS. The EMBO Journal 37:16.
Crossref
Crossref
Patrizia Bossolasco, Francesca Sassone, Valentina Gumina, Silvia Peverelli, Maria Garzo & Vincenzo Silani. (2018) Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient. Stem Cell Research 30, pages 61-68.
Crossref
Crossref
T.H. Wang, S.Y. Wang, X.D. Wang, H.Q. Jiang, Y.Q. Yang, Y. Wang, J.L. Cheng, C.T. Zhang, W.W. Liang & H.L. Feng. (2018) Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERK. Neuroscience 379, pages 152-166.
Crossref
Crossref
Jianguo Liu, Elise Allender, Jiajing Wang, Eleanor H. Simpson, Jeffrey A. Loeb & Fei Song. (2018) Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation. Neurobiology of Disease 111, pages 118-126.
Crossref
Crossref
Natalia Salvadores, Mario Sanhueza, Patricio Manque & Felipe A. Court. (2017) Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders. Frontiers in Neuroscience 11.
Crossref
Crossref
Roland Patai, Melinda Paizs, Massimo Tortarolo, Caterina Bendotti, Izabella Obál, József I. Engelhardt & László Siklós. (2017) Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:7, pages 1739-1748.
Crossref
Crossref
Qin-Ming Zhou, Jing-Jing Zhang, Song Li, Sheng Chen & Wei-Dong Le. (2017)
n
-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1
G93A
mouse model of amyotrophic lateral sclerosis
. CNS Neuroscience & Therapeutics 23:5, pages 375-385.
Crossref
Crossref
John D Lee, Vinod Kumar, Jenny N T Fung, Marc J Ruitenberg, Peter G Noakes & Trent M Woodruff. (2017)
Pharmacological inhibition of complement C5a-C5a
1
receptor signalling ameliorates disease pathology in the hSOD1
G93A
mouse model of amyotrophic lateral sclerosis
. British Journal of Pharmacology 174:8, pages 689-699.
Crossref
Crossref
Sagit Golko-Perez, Tamar Amit, Orit Bar-Am, Moussa B.H. Youdim & Orly Weinreb. (2016) A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice. Neurotoxicity Research 31:2, pages 230-244.
Crossref
Crossref
MelissaM Haulcomb, RenaM Meadows, WhitneyM Miller, KathrynP McMillan, MeKenzieJ Hilsmeyer, Xuefu Wang, WesleyT Beaulieu, StephanieL Dickinson, ToddJ Brown, VirginiaM Sanders & KathrynJ Jones. (2017) Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis. Neural Regeneration Research 12:10, pages 1664.
Crossref
Crossref
Alexander McGown, Dame Pamela J. Shaw & Tennore Ramesh. (2016) ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis. Molecular Neurodegeneration 11:1.
Crossref
Crossref
Tamara Seredenina, Zeynab Nayernia, Silvia Sorce, Ghassan J. Maghzal, Aleksandra Filippova, Shuo-Chien Ling, Olivier Basset, Olivier Plastre, Youssef Daali, Elisabeth J. Rushing, Maria T. Giordana, Don W. Cleveland, Adriano Aguzzi, Roland Stocker, Karl-Heinz Krause & Vincent Jaquet. (2016) Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. Free Radical Biology and Medicine 97, pages 95-108.
Crossref
Crossref
Sebastian A. Lewandowski, Ingrid Nilsson, Linda Fredriksson, Peter Lönnerberg, Lars Muhl, Manuel Zeitelhofer, Milena Z. Adzemovic, Susanne Nichterwitz, Daniel A. Lawrence, Eva Hedlund & Ulf Eriksson. (2015) Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration. Acta Neuropathologica 131:3, pages 453-464.
Crossref
Crossref
Sagit Golko-Perez, Silvia Mandel, Tamar Amit, Lana Kupershmidt, Moussa B. H. Youdim & Orly Weinreb. (2015) Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotoxicity Research 29:2, pages 208-217.
Crossref
Crossref
Melissa M. Haulcomb, Nichole A. Mesnard-Hoaglin, Richard J. Batka, Rena M. Meadows, Whitney M. Miller, Kathryn P. Mcmillan, Todd J. Brown, Virginia M. Sanders & Kathryn J. Jones. (2015)
Identification of B6SJL mSOD1
G93A
mouse subgroups with different disease progression rates
. Journal of Comparative Neurology 523:18, pages 2752-2768.
Crossref
Crossref
Jia Y Lee, John D Lee, Simon Phipps, Peter G Noakes & Trent M Woodruff. (2015) Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Neuroinflammation 12:1.
Crossref
Crossref
Renzo Mancuso & Xavier Navarro. (2015) Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic. Progress in Neurobiology 133, pages 1-26.
Crossref
Crossref
Fernando G. Vieira, Qinggong Ping, Andy J. Moreno, Joshua D. Kidd, Kenneth Thompson, Bingbing Jiang, John M. Lincecum, Monica Z. Wang, Gerard S. De Zutter, Valerie R. Tassinari, Beth Levine, Theo Hatzipetros, Alan Gill & Steven Perrin. (2015) Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLOS ONE 10:8, pages e0135570.
Crossref
Crossref
Y. Li, Y. Guo, X. Wang, X. Yu, W. Duan, K. Hong, J. Wang, H. Han & C. Li. (2015) Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience 298, pages 12-25.
Crossref
Crossref
Kevin X. Liu, Benjamin Edwards, Sheena Lee, Mattéa J. Finelli, Ben Davies, Kay E. Davies & Peter L. Oliver. (2015) Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. Brain 138:5, pages 1167-1181.
Crossref
Crossref
Michael Jablonski, David S. Miller, Piera Pasinelli & Davide Trotti. (2015) ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis. Brain Research 1607, pages 1-14.
Crossref
Crossref
Eiichi Tokuda, Shunsuke Watanabe, Eriko Okawa & Shin-ichi Ono. (2015) Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:2, pages 461-476.
Crossref
Crossref
Julie A. Kelly, Noreen T. Boyle, Natalie Cole, Gillian R. Slator, M. Alessandra Colivicchi, Chiara Stefanini, Oliviero L. Gobbo, Gaia A. Scalabrino, Sinead M. Ryan, Marwa Elamin, Cathal Walsh, Alice Vajda, Margaret M. Goggin, Matthew Campbell, Deborah C. Mash, Shane M. O'Mara, David J. Brayden, John J. Callanan, Keith F. Tipton, Laura Della Corte, Jackie Hunter, Kathy M. O'Boyle, Carvell H. Williams & Orla Hardiman. (2015) First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology 89, pages 193-203.
Crossref
Crossref
Marianna Marino, Simonetta Papa, Valeria Crippa, Giovanni Nardo, Marco Peviani, Cristina Cheroni, Maria Chiara Trolese, Eliana Lauranzano, Valentina Bonetto, Angelo Poletti, Silvia DeBiasi, Laura Ferraiuolo, Pamela J. Shaw & Caterina Bendotti. (2015) Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis. Neurobiology of Aging 36:1, pages 492-504.
Crossref
Crossref
Daniel Cacabelos, Victoria Ayala, Omar Ramírez-Nunez, Ana Belen Granado-Serrano, Jordi Boada, Jose C. E. Serrano, Rosanna Cabré, Gisela Nadal-Rey, Maria Josep Bellmunt, Isidro Ferrer, Reinald Pamplona & Manuel Portero-Otin. (2014) Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications of an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner. NeuroMolecular Medicine 16:4, pages 669-685.
Crossref
Crossref
Renzo Mancuso, Rosario Osta & Xavier Navarro. (2014)
Presymptomatic electrophysiological tests predict clinical onset and survival in SOD1
G93A
ALS mice
. Muscle & Nerve 50:6, pages 943-949.
Crossref
Crossref
Ellen J. Bennett, Richard J. Mead, Mimoun Azzouz, Pamela J. Shaw & Andrew J. Grierson. (2014) Early Detection of Motor Dysfunction in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels. PLoS ONE 9:9, pages e107918.
Crossref
Crossref
H.-Q. Jiang, M. Ren, H.-Z. Jiang, J. Wang, J. Zhang, X. Yin, S.-Y. Wang, Y. Qi, X.-D. Wang & H.-L. Feng. (2014) Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 277, pages 132-138.
Crossref
Crossref
Qiongman Kong, Ling-Chu Chang, Kou Takahashi, Qibing Liu, Delanie A. Schulte, Liching Lai, Brian Ibabao, Yuchen Lin, Nathan Stouffer, Chitra Das Mukhopadhyay, Xuechao Xing, Kathleen I. Seyb, Gregory D. Cuny, Marcie A. Glicksman & Chien-Liang Glenn Lin. (2014) Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. Journal of Clinical Investigation 124:3, pages 1255-1267.
Crossref
Crossref
Marco Peviani, Eleonora Salvaneschi, Leonardo Bontempi, Alessandro Petese, Antonio Manzo, Daniela Rossi, Mario Salmona, Simona Collina, Paolo Bigini & Daniela Curti. (2014) Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiology of Disease 62, pages 218-232.
Crossref
Crossref
Alan E Renton, Adriano Chiò & Bryan J Traynor. (2013) State of play in amyotrophic lateral sclerosis genetics. Nature Neuroscience 17:1, pages 17-23.
Crossref
Crossref
Ana Catarina Vieira de Castro & I. Anna S. Olsson. 2015. Ethical Issues in Behavioral Neuroscience. Ethical Issues in Behavioral Neuroscience
47
78
.
Yan Jouroukhin, Regina Ostritsky, Yaniv Assaf, Galit Pelled, Eliezer Giladi & Illana Gozes. (2013) NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport. Neurobiology of Disease 56, pages 79-94.
Crossref
Crossref
Eiichi Tokuda, Eriko Okawa, Shunsuke Watanabe, Shin-ichi Ono & Stefan L. Marklund. (2013) Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiology of Disease 54, pages 308-319.
Crossref
Crossref
Martin R Turner, Orla Hardiman, Michael Benatar, Benjamin R Brooks, Adriano Chio, Mamede de Carvalho, Paul G Ince, Cindy Lin, Robert G Miller, Hiroshi Mitsumoto, Garth Nicholson, John Ravits, Pamela J Shaw, Michael Swash, Kevin Talbot, Bryan J Traynor, Leonard H Van den Berg, Jan H Veldink, Steve Vucic & Matthew C Kiernan. (2013) Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology 12:3, pages 310-322.
Crossref
Crossref
Lin ZhouYing HouQidong YangXiaoping DuMin LiMei YuanZhiwen Zhou. (2012)
Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β
1–42
-injected rats and may be connected to synaptic changes in the hippocampus
. Canadian Journal of Physiology and Pharmacology 90:11, pages 1446-1455.
Crossref
Crossref
John Hardy. (2012)
CSF
biomarking for diagnosis and treatment assessment in neurodegeneration
. Journal of Neurochemistry 123:3, pages 339-341.
Crossref
Crossref
Yan Jouroukhin, Regina Ostritsky & Illana Gozes. (2012) D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy. Journal of Molecular Neuroscience 48:3, pages 597-602.
Crossref
Crossref
Rachel Tesla, Hamilton Parker Wolf, Pin Xu, Jordan Drawbridge, Sandi Jo Estill, Paula Huntington, LaTisha McDaniel, Whitney Knobbe, Aaron Burket, Stephanie Tran, Ruth Starwalt, Lorraine Morlock, Jacinth Naidoo, Noelle S. Williams, Joseph M. Ready, Steven L. McKnight & Andrew A. Pieper. (2012) Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences 109:42, pages 17016-17021.
Crossref
Crossref
Qiongman Kong, Sarah Carothers, Yueming Chang & Chien‐Liang Glenn Lin. (2012)
The Importance of Preclinical Trial Timing – a Potential Reason for the Disconnect between mouse Studies and Human Clinical Trials in
ALS
. CNS Neuroscience & Therapeutics 18:9, pages 791-793.
Crossref
Crossref
Luc Dupuis, Reinhard Dengler, Michael T. Heneka, Thomas Meyer, Stephan Zierz, Jan Kassubek, Wilhelm Fischer, Franziska Steiner, Eva Lindauer, Markus Otto, Jens Dreyhaupt, Torsten Grehl, Andreas Hermann, Andrea S. Winkler, Ulrich Bogdahn, Reiner Benecke, Bertold Schrank, Carsten Wessig, Julian Grosskreutz & Albert C. Ludolph. (2012) A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis. PLoS ONE 7:6, pages e37885.
Crossref
Crossref
Lana Kupershmidt, Tamar Amit, Orit Bar-Am, Moussa B.H. Youdim & Orly Weinreb. (2012) Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice. Mechanisms of Ageing and Development 133:5, pages 267-274.
Crossref
Crossref
Xinhong Feng, Ying Peng, Mingsheng Liu & Liying Cui. (2012) dl-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology 62:2, pages 1004-1010.
Crossref
Crossref
Richard J. Mead, Ellen J. Bennett, Aneurin J. Kennerley, Paul Sharp, Claire Sunyach, Paul Kasher, Jason Berwick, Brigitte Pettmann, Guiseppe Battaglia, Mimoun Azzouz, Andrew Grierson & Pamela J. Shaw. (2011) Optimised and Rapid Pre-clinical Screening in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS). PLoS ONE 6:8, pages e23244.
Crossref
Crossref
Sarah Knippenberg, Nadine Thau, Reinhard Dengler & Susanne Petri. (2010) Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behavioural Brain Research 213:1, pages 82-87.
Crossref
Crossref
Petra Steinacker, Andreas Hawlik, Stefan Lehnert, Olaf Jahn, Stephen Meier, Evamaria Görz, Kerstin E. Braunstein, Marija Krzovska, Birgit Schwalenstöcker, Sarah Jesse, Christian Pröpper, Tobias Böckers, Albert Ludolph & Markus Otto. (2010) Neuroprotective Function of Cellular Prion Protein in a Mouse Model of Amyotrophic Lateral Sclerosis. The American Journal of Pathology 176:3, pages 1409-1420.
Crossref
Crossref
R. W. Orrell. (2009) Motor neuron disease: systematic reviews of treatment for ALS and SMA. British Medical Bulletin 93:1, pages 145-159.
Crossref
Crossref
Anne K. Meyer, Martina Maisel, Andreas Hermann, Katja Stirl & Alexander Storch. (2010) Restorative approaches in Parkinson's Disease: Which cell type wins the race?. Journal of the Neurological Sciences 289:1-2, pages 93-103.
Crossref
Crossref
Lana Kupershmidt, Orly Weinreb, Tamar Amit, Silvia Mandel, Maria Teresa Carri & Moussa B. H. Youdim. (2009) Neuroprotective and neuritogenic activities of novel multimodal iron‐chelating drugs in motor‐neuron‐like NSC‐34 cells and transgenic mouse model of amyotrophic lateral sclerosis. The FASEB Journal 23:11, pages 3766-3779.
Crossref
Crossref
Albert C. LudolphSarah Jesse. (2009) Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials. Therapeutic Advances in Neurological Disorders 2:5, pages 319-326.
Crossref
Crossref
A. C. Ludolph, J. Kassubek, B. G. Landwehrmeyer, E. Mandelkow, E.-M. Mandelkow, D. J. Burn, D. Caparros-Lefebvre, K. A. Frey, J. G. de Yebenes, T. Gasser, P. Heutink, G. Höglinger, Z. Jamrozik, K. A. Jellinger, A. Kazantsev, H. Kretzschmar, A. E. Lang, I. Litvan, J. J. Lucas, P. L. McGeer, S. Melquist, W. Oertel, M. Otto, D. Paviour, T. Reum, A. Saint-Raymond, J. C. Steele, M. Tolnay, H. Tumani, J. C. van Swieten, M. T. Vanier, J.-P. Vonsattel, S. Wagner & Z. K. Wszolek. (2009) Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. European Journal of Neurology 16:3, pages 297-309.
Crossref
Crossref
Martin R Turner, Matthew C Kiernan, P Nigel Leigh & Kevin Talbot. (2009) Biomarkers in amyotrophic lateral sclerosis. The Lancet Neurology 8:1, pages 94-109.
Crossref
Crossref
Bernadett Kalmar, Sergey Novoselov, Anna Gray, Michael E. Cheetham, Boris Margulis & Linda Greensmith. (2008) Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS. Journal of Neurochemistry 107:2, pages 339-350.
Crossref
Crossref
Vincenzo Silani & Lidia Cova. (2008) Stem cell transplantation in Multiple Sclerosis: Safety and Ethics. Journal of the Neurological Sciences 265:1-2, pages 116-121.
Crossref
Crossref
Jacqueline Montes, Caterina Bendotti, Massimo Tortarolo, Cristina Cheroni, Hussein Hallak, Zipora Speiser, Sari Goren, Eran Blaugrund & Paul H. Gordon. 2008. Animal and Translational Models for CNS Drug Discovery. Animal and Translational Models for CNS Drug Discovery
267
310
.
Trent M. Woodruff, Kerina J. Costantini, Steve M. Taylor & Peter G. Noakes. 2008. Current Topics in Complement II. Current Topics in Complement II
136
151
.
Paul H Gordon, Dan H Moore, Robert G Miller, Julaine M Florence, Joseph L Verheijde, Carolyn Doorish, Joan F Hilton, G Mark Spitalny, Robert B MacArthur, Hiroshi Mitsumoto, Hans E Neville, Kevin Boylan, Tahseen Mozaffar, Jerry M Belsh, John Ravits, Richard S Bedlack, Michael C Graves, Leo F McCluskey, Richard J Barohn & Rup Tandan. (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. The Lancet Neurology 6:12, pages 1045-1053.
Crossref
Crossref